Clinical Trial Update: Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel [Phase 2, Phase 3]

View source ↗

Summary

A completed clinical trial update evaluating cabazitaxel for locally advanced or metastatic transitional cell carcinoma across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transitional Cell Carcinoma

Drugs mentioned

• Cabazitaxel (cabazitaxel)

Snippet

Sponsor: Dr Anjali Zarkar | Conditions: Transitional Cell Carcinoma | Phase 2, Phase 3 | Status: COMPLETED